Novadip Biosciences

Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.

Novadip Biosciences headquartered in Europe, operates in the Biotechnology, Health Care, Medical, Therapeutics sector. The company focuses on Biotechnology and has secured $5.9B in funding across 64 round(s). With a team of 11-50 employees, Novadip Biosciences is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Novadip Biosciences, raised $31.6M. Discover more about their projects, partnerships, and impact on our platform.